Format

Send to:

Choose Destination
See comment in PubMed Commons below
Postgrad Med J. 1998 Jun;74(872):363-4.

Further hearing loss during osteoporosis treatment with etidronate.

Author information

  • 1Dokuz Eylül University, Medical Faculty, Inciralti, Izmir, Turkey.

Abstract

Ototoxicity is a rare and disabling complication in bisphosphonate therapy. Here we describe two patients who encountered further hearing loss during oral etidronate treatment for osteoporosis.

PMID:
9799894
[PubMed - indexed for MEDLINE]
PMCID:
PMC2360958
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for HighWire Icon for PubMed Central
    Loading ...
    Write to the Help Desk